Ginsenoside Rg3 inhibits the biological activity of SGC‐7901

Abstract Aim To explore the suppressive effects of ginsenoside Rg3 on the biological activities of gastric cancer and the mechanisms responsible therein, by conducting an in vitro study. Materials and Methods SGC‐7901 gastric cancer cells were divided into NC, DMSO, Gin‐Low (10 mg/L), Gin‐Middle (20...

Full description

Bibliographic Details
Main Authors: Qing Yang, Ning Cai, Daobiao Che, Xing Chen, Dongliang Wang
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Food Science & Nutrition
Subjects:
Online Access:https://doi.org/10.1002/fsn3.1707
_version_ 1797661234061901824
author Qing Yang
Ning Cai
Daobiao Che
Xing Chen
Dongliang Wang
author_facet Qing Yang
Ning Cai
Daobiao Che
Xing Chen
Dongliang Wang
author_sort Qing Yang
collection DOAJ
description Abstract Aim To explore the suppressive effects of ginsenoside Rg3 on the biological activities of gastric cancer and the mechanisms responsible therein, by conducting an in vitro study. Materials and Methods SGC‐7901 gastric cancer cells were divided into NC, DMSO, Gin‐Low (10 mg/L), Gin‐Middle (20 mg/L), and Gin‐High (40 mg/L) groups. Using MTT, flow cytometry, transwell, and wound‐healing assays, the cell biological activities in the different groups were evaluated; the protein expression levels of PTEN, p‐PI3K, AKT, and P53 were measured by Western blot assay, and p‐PI3K nuclear volume was evaluated by immunofluorescence. Results The SGC‐7901 cell proliferation rate was depressed significantly, and cell apoptosis increased significantly while cells were arrested in the G1 phase (p < .05) with ginsenoside Rg3 treatment in a dose‐dependent manner (p < .05). Meanwhile, the SGC‐7901 cell invasion number and wound‐healing rate of ginsenoside Rg3‐treated groups were significantly downregulated compared with those of the NC group, also in a dose‐dependent manner (p < .05). PTEN and P53 protein expression levels were significantly increased, and p‐PI3K and AKT protein expression levels were significantly depressed in ginsenoside Rg3‐treated groups in a dose‐dependent manner (p < .05). Conclusion Ginsenoside Rg3 suppresses gastric cancer via regulation of the PTEN/p‐PI3K/AKT pathway.
first_indexed 2024-03-11T18:41:28Z
format Article
id doaj.art-2c430552d9254830a8bf30406d698543
institution Directory Open Access Journal
issn 2048-7177
language English
last_indexed 2024-03-11T18:41:28Z
publishDate 2020-08-01
publisher Wiley
record_format Article
series Food Science & Nutrition
spelling doaj.art-2c430552d9254830a8bf30406d6985432023-10-12T12:06:11ZengWileyFood Science & Nutrition2048-71772020-08-01884151415810.1002/fsn3.1707Ginsenoside Rg3 inhibits the biological activity of SGC‐7901Qing Yang0Ning Cai1Daobiao Che2Xing Chen3Dongliang Wang4Department of Hospital Pharmacy Suqian First Hospital Suqian ChinaDepartment of Hospital Pharmacy Suqian First Hospital Suqian ChinaDepartment of Hospital Pharmacy Suqian First Hospital Suqian ChinaDepartment of Hospital Pharmacy Suqian First Hospital Suqian ChinaEmergency Department Suqian First Hospital Suqian ChinaAbstract Aim To explore the suppressive effects of ginsenoside Rg3 on the biological activities of gastric cancer and the mechanisms responsible therein, by conducting an in vitro study. Materials and Methods SGC‐7901 gastric cancer cells were divided into NC, DMSO, Gin‐Low (10 mg/L), Gin‐Middle (20 mg/L), and Gin‐High (40 mg/L) groups. Using MTT, flow cytometry, transwell, and wound‐healing assays, the cell biological activities in the different groups were evaluated; the protein expression levels of PTEN, p‐PI3K, AKT, and P53 were measured by Western blot assay, and p‐PI3K nuclear volume was evaluated by immunofluorescence. Results The SGC‐7901 cell proliferation rate was depressed significantly, and cell apoptosis increased significantly while cells were arrested in the G1 phase (p < .05) with ginsenoside Rg3 treatment in a dose‐dependent manner (p < .05). Meanwhile, the SGC‐7901 cell invasion number and wound‐healing rate of ginsenoside Rg3‐treated groups were significantly downregulated compared with those of the NC group, also in a dose‐dependent manner (p < .05). PTEN and P53 protein expression levels were significantly increased, and p‐PI3K and AKT protein expression levels were significantly depressed in ginsenoside Rg3‐treated groups in a dose‐dependent manner (p < .05). Conclusion Ginsenoside Rg3 suppresses gastric cancer via regulation of the PTEN/p‐PI3K/AKT pathway.https://doi.org/10.1002/fsn3.1707AKTbiological activitiesgastric cancerginsenoside Rg3p‐PI3KPTEN
spellingShingle Qing Yang
Ning Cai
Daobiao Che
Xing Chen
Dongliang Wang
Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
Food Science & Nutrition
AKT
biological activities
gastric cancer
ginsenoside Rg3
p‐PI3K
PTEN
title Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
title_full Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
title_fullStr Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
title_full_unstemmed Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
title_short Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
title_sort ginsenoside rg3 inhibits the biological activity of sgc 7901
topic AKT
biological activities
gastric cancer
ginsenoside Rg3
p‐PI3K
PTEN
url https://doi.org/10.1002/fsn3.1707
work_keys_str_mv AT qingyang ginsenosiderg3inhibitsthebiologicalactivityofsgc7901
AT ningcai ginsenosiderg3inhibitsthebiologicalactivityofsgc7901
AT daobiaoche ginsenosiderg3inhibitsthebiologicalactivityofsgc7901
AT xingchen ginsenosiderg3inhibitsthebiologicalactivityofsgc7901
AT dongliangwang ginsenosiderg3inhibitsthebiologicalactivityofsgc7901